IFNG and neoplasm: Therefore, we hypothesise that for patients with metastases emerging via the hematogenous route, the barriers of blood vessels for tumour cell spreading are lowered due to the impaired antitumour immune response that is caused by IFN-γ response signalling, and immunotherapy should be effective in these patients.